St. Elisabeth-Krankenhaus
About St. Elisabeth-Krankenhaus
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Lead Sponsor
# Trials
Hoffmann-La Roche
2
AGO Research GmbH
1
AIO-Studien-gGmbH
1
Alliance Foundation Trials, LLC.
1
Arcagy Research
1
Boehringer Ingelheim
1
Karolinska University Hospital
1
Spanish Breast Cancer Research Group
1
Clinical Trials at St. Elisabeth-Krankenhaus
During the past decade, St. Elisabeth-Krankenhaus conducted 5 clinical trials. In the 10-year time frame, 5 clinical trials started and 2 clinical trials were completed, i.e. on
average, 40% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 0 clinical trials were completed. i.e. 0%
of trials that started reached the finish line.
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
Bevacizumab + Endocrine Treatment vs Endocrine Treatment as First Line in Postmenopausal Women
2007-11-06
2014-07-24
Completed
380
Panther: A Study Comparing Biweekly and Tailored EC-T Versus Three Weekly FEC-T in Breast Cancer Patients
2007-02-01
2022-01-01
Unknown status
2,017
LUX-Breast 1: BIBW 2992 (Afatinib) in HER2-positive Metastatic Breast Cancer Patients After One Prior Herceptin Treatment
2010-06-22
2018-07-06
Completed
508
Study To Evaluate the Efficacy and Safety Of Bevacizumab, and Associated Biomarkers, In Combination With Paclitaxel Compared With Paclitaxel Plus Placebo as First-line Treatment Of Patients With Her2-Negative Metastatic Breast Cancer
2012-08-27
2017-11-21
Completed
481
Randomized, Open Label, Clinical Study of the Targeted Therapy, Palbociclib, to Treat Metastatic Breast Cancer
2017-06-21
2026-03-31
Active, not recruiting
496
2nd-line Therapy With Nal-IRI After Gem/Nab-pac in Advanced Pancreatic Cancer - Predictive Role of 1st-line Therapy
2018-03-31
2023-05-30
Active, not recruiting
270
A Study Comparing Atezolizumab (Anti PD-L1 Antibody) In Combination With Adjuvant Anthracycline/Taxane-Based Chemotherapy Versus Chemotherapy Alone In Patients With Operable Triple-Negative Breast Cancer
2018-08-02
2025-08-24
Active, not recruiting
2,300
Clinical Trials Sponsors and Collaborators
Out of the total clinical trials conducted in "St. Elisabeth-Krankenhaus" #1 sponsor was "Hoffmann-La Roche" with 2 trials, followed by "AGO Research GmbH" with 1 trials
sponsored, "AIO-Studien-gGmbH" with 1 trials sponsored, "Alliance Foundation Trials, LLC." with 1 trials sponsored and "Arcagy Research"
with 1 trials sponsored. Other sponsors include -2 different institutions and
companies that sponsored additional 8 trials in total.
In terms of collaborators to trials, out of the total clinical trials conducted in "St. Elisabeth-Krankenhaus"
#1 collaborator was "German Breast Group" with 3 trials as a collaborator, "Alliance Foundation Trials (AFT)" with 1 trials as a collaborator, "Arbeitsgemeinschaft Gynaekologische Onkologie Austria" with 1 trials as a collaborator, "Arbeitsgemeinschaft Gynaekologishe Onkologie Germany" with 1 trials as a collaborator and "Austrian Breast & Colorectal Cancer Study Group" with 1 trials as a collaborator. Other collaborators include 15 different institutions and companies that were
collaborators in the rest 25 trials.
Clinical Trials Conditions at St. Elisabeth-Krankenhaus
According to Clinical.Site data, the most researched conditions in "St. Elisabeth-Krankenhaus" are
"Breast Cancer" (2 trials), "Breast Neoplasms" (1 trials), "Estrogen Receptor Positive Breast Cancer" (1 trials), "HER-2 Positive Breast Cancer" (1 trials) and "Locally Advanced Pancreatic Cancer" (1 trials). Many other conditions were trialed in "St. Elisabeth-Krankenhaus" in a lesser frequency.
Clinical Trials Intervention Types at St. Elisabeth-Krankenhaus
Most popular intervention types in "St. Elisabeth-Krankenhaus" are "Drug" (9 trials). Other intervention types were less common.
The name of intervention was led by "Paclitaxel" (3 trials), "Fulvestrant" (2 trials), "Placebo" (2 trials), "trastuzumab" (2 trials) and "Anastrozole" (1 trials). Other intervention names were less common.
Clinical Trials Genders at St. Elisabeth-Krankenhaus
The vast majority of trials in "St. Elisabeth-Krankenhaus" are
5 trials for "Female" genders and 4 trials for "All" genders.
Clinical Trials Status at St. Elisabeth-Krankenhaus
Currently, there are NaN active trials in "St. Elisabeth-Krankenhaus".
undefined are not yet recruiting,
1 are recruiting,
3 are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 4 completed trials in St. Elisabeth-Krankenhaus,
undefined suspended trials,
and undefined terminated clinical trials to date.
Out of the total trials that were conducted in St. Elisabeth-Krankenhaus, 0 "Phase 1"
clinical trials were conducted, 1 "Phase 2" clinical
trials and 8 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 0 trials, and there were
also 0 trials that are defined as “Not Applicable".